GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Enterprise Value
中文

Chemical Works of Gedeon Richter (BUD:RICHTER) Enterprise Value

: Ft1,574,309 Mil (As of Today)
View and export this data going back to 1994. Start your Free Trial

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Chemical Works of Gedeon Richter's Enterprise Value is Ft1,574,309 Mil. Chemical Works of Gedeon Richter's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was Ft418,835 Mil. Therefore, Chemical Works of Gedeon Richter's EV-to-EBIT ratio for today is 3.76.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Chemical Works of Gedeon Richter's Enterprise Value is Ft1,574,309 Mil. Chemical Works of Gedeon Richter's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was Ft469,643 Mil. Therefore, Chemical Works of Gedeon Richter's EV-to-EBITDA ratio for today is 3.35.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Chemical Works of Gedeon Richter's Enterprise Value is Ft1,574,309 Mil. Chemical Works of Gedeon Richter's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1,632,030 Mil. Therefore, Chemical Works of Gedeon Richter's EV-to-Revenue ratio for today is 0.96.


Chemical Works of Gedeon Richter Enterprise Value Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,082,064.50 1,253,892.36 1,594,013.00 1,450,204.80 1,547,694.75

Chemical Works of Gedeon Richter Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,450,204.80 1,266,228.45 1,510,893.32 1,571,867.30 1,547,694.75

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter Enterprise Value Distribution

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Enterprise Value falls into.



Chemical Works of Gedeon Richter Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Chemical Works of Gedeon Richter's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Chemical Works of Gedeon Richter's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemical Works of Gedeon Richter  (BUD:RICHTER) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Chemical Works of Gedeon Richter's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1574309.085/418835
=3.76

Chemical Works of Gedeon Richter's current Enterprise Value is Ft1,574,309 Mil.
Chemical Works of Gedeon Richter's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft418,835 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Chemical Works of Gedeon Richter's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1574309.085/469643
=3.35

Chemical Works of Gedeon Richter's current Enterprise Value is Ft1,574,309 Mil.
Chemical Works of Gedeon Richter's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft469,643 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Chemical Works of Gedeon Richter's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1574309.085/1632030
=0.96

Chemical Works of Gedeon Richter's current Enterprise Value is Ft1,574,309 Mil.
Chemical Works of Gedeon Richter's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft1,632,030 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemical Works of Gedeon Richter Enterprise Value Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Traded in Other Exchanges
Address
Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines